Literature DB >> 23064565

Cardiac angiosarcoma presenting with tamponade.

Elie Chalhoub1, Bassam I Mattar, Wassim Shaheen, Thomas K Schulz.   

Abstract

Primary cardiac angiosarcoma is extremely rare, but it is the most common primary malignant cardiac tumor. We herein present the case of a 51-year-old man who presented with symptoms of acute right heart failure, secondary to pericardial tamponade. Pericardiocentesis showed bloody fluid with negative pathology. Repeat 2-D echocardiography and a trans-esophageal echocardiogram showed a right atrial mass. The patient underwent surgery and adjuvant chemotherapy, but died seven months after the diagnosis. Despite being rare, cardiac angiosarcoma should be included in the differential diagnosis of bloody pericardial effusions, even with negative early investigations. The prognosis of the disease is usually poor. Treatment is mainly surgical resection if the cancer is localized, and can include neadjuvant and adjuvant chemotherapy, radiation treatment, and immunotherapy.

Entities:  

Mesh:

Year:  2012        PMID: 23064565     DOI: 10.2169/internalmedicine.51.7704

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Surgical and multitreatment approach in a case of primary cardiac angiosarcoma: A case report.

Authors:  Akihiro Kobayashi; Yoshimori Araki; Takafumi Terada; Sachie Terazawa; Osamu Kawaguchi
Journal:  Int J Surg Case Rep       Date:  2022-06-24

2.  Fast growing angiosarcoma of the right atrium after radiofrequency catheter ablation: a missed diagnosis or misdiagnosis case report.

Authors:  Yi Yu; Qunshan Wang; Jian Sun; Jing Zhao; Suyun Chen; Yigang Li
Journal:  BMC Cancer       Date:  2020-01-06       Impact factor: 4.430

Review 3.  Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy: A case report and literature review.

Authors:  Cuiwei Liu; Yanxia Zhao; Zhongyuan Yin; Ting Hu; Jinghua Ren; Jielin Wei; Linka Xie; Jie Xiong; Hongge Wu; Xiaofang Dai; Shihong Fei
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.